Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway. [electronic resource]
Producer: 20180907Description: 178-183 p. digitalISSN:- 2299-5684
- Cells, Cultured
- Cellular Microenvironment
- Collagenases -- genetics
- Coronary Vessels -- drug effects
- Dose-Response Relationship, Drug
- Exenatide
- Glucagon-Like Peptide-1 Receptor -- metabolism
- Humans
- Incretins -- pharmacology
- Matrix Metalloproteinase 1 -- genetics
- Matrix Metalloproteinase 2 -- genetics
- Matrix Metalloproteinase 9 -- genetics
- Muscle, Smooth, Vascular -- drug effects
- Myocytes, Smooth Muscle -- drug effects
- Peptides -- pharmacology
- Phosphorylation
- Proto-Oncogene Proteins c-akt -- metabolism
- Signal Transduction -- drug effects
- Tissue Inhibitor of Metalloproteinase-1 -- genetics
- Tissue Inhibitor of Metalloproteinase-2 -- genetics
- Tumor Necrosis Factor-alpha -- pharmacology
- Venoms -- pharmacology
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.